Erythrocyte membrane fatty acid composition as a marker of dietary compliance in hyperlipidaemic subjects. 1995

M B Tynan, and D P Nicholls, and S M Maguire, and I C Steele, and C McMaster, and R Moore, and E R Trimble, and J Pearce
Department of Medicine, Royal Victoria Hospital, Belfast, UK.

Dietary intervention is the first treatment step in management of hyperlipidaemia, but there are few objective criteria of compliance. Whether intensive dietary intervention would produce a detectable change in erythrocyte membrane fatty acid composition which could be used as a marker of compliance was examined in 31 new hyperlipidaemic patients. Over a 6 month period, body mass index fell from 29.0 to 26.9 kg/m2 (P < 0.001) and total cholesterol by 19% from 8.16 to 6.58 mmol/l (P < 0.001). The energy derived from fat was reduced from 38.5% to 29.6% (P < 0.001), and the ratio of dietary polyunsaturated to saturated (P:S) fatty acids in the diet increased from 0.45 to 0.66 (P < 0.01). Small but significant changes were recorded in several red cell membrane fatty acids, and the P:S ratio increased from 0.91 to 1.13 (P < 0.001). It would appear, therefore, that red cell membrane changes parallel dietary changes and hence are a potential marker for compliance with dietary changes.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M B Tynan, and D P Nicholls, and S M Maguire, and I C Steele, and C McMaster, and R Moore, and E R Trimble, and J Pearce
July 1994, Annals of clinical biochemistry,
M B Tynan, and D P Nicholls, and S M Maguire, and I C Steele, and C McMaster, and R Moore, and E R Trimble, and J Pearce
July 2022, BioFactors (Oxford, England),
M B Tynan, and D P Nicholls, and S M Maguire, and I C Steele, and C McMaster, and R Moore, and E R Trimble, and J Pearce
June 2023, The international journal of neuropsychopharmacology,
M B Tynan, and D P Nicholls, and S M Maguire, and I C Steele, and C McMaster, and R Moore, and E R Trimble, and J Pearce
September 2000, Metabolism: clinical and experimental,
M B Tynan, and D P Nicholls, and S M Maguire, and I C Steele, and C McMaster, and R Moore, and E R Trimble, and J Pearce
June 2004, Puerto Rico health sciences journal,
M B Tynan, and D P Nicholls, and S M Maguire, and I C Steele, and C McMaster, and R Moore, and E R Trimble, and J Pearce
February 2009, European journal of pediatrics,
M B Tynan, and D P Nicholls, and S M Maguire, and I C Steele, and C McMaster, and R Moore, and E R Trimble, and J Pearce
January 2006, Annals of nutrition & metabolism,
M B Tynan, and D P Nicholls, and S M Maguire, and I C Steele, and C McMaster, and R Moore, and E R Trimble, and J Pearce
November 1999, Diabetes research and clinical practice,
M B Tynan, and D P Nicholls, and S M Maguire, and I C Steele, and C McMaster, and R Moore, and E R Trimble, and J Pearce
January 1987, Journal of pediatric gastroenterology and nutrition,
M B Tynan, and D P Nicholls, and S M Maguire, and I C Steele, and C McMaster, and R Moore, and E R Trimble, and J Pearce
August 1990, Diabetes research (Edinburgh, Scotland),
Copied contents to your clipboard!